YTE reported $696.02M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Agenus AGEN:US $ 25.4M 6.02M
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Amgen AMGN:US $ 4677M 451M
Biocryst Pharmaceuticals BCRX:US $ 49.68M 2.95M
Biogen BIIB:US $ 1777.9M 295.8M
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Bristol Myers Squibb BMY:US $ 9177M 452M
ChemoCentryx CCXI:US 5.25M 3.24M
Clovis Oncology CLVS:US $ 24.83M 1.4M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Exelixis EXEL:US $ 342.78M 95.45M
Gilead Sciences GILD:US $ 5166M 549M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
IONIS PHARMACEUT IONS:US $ 438M 307.99M
MacroGenics MGNX:US 11.05M 2.15M
Merk MRK:US $ 10567M 873M
Moderna Inc MRNA:US 5.05B 1.21B
Nektar Therapeutics NKTR:US $ 18.85M 0.76M
Neurocrine Biosciences NBIX:US $ 306M 1.9M
Novartis NOVN:VX 9.52B 3M
Novartis NVS:US $ 9059M 463M
Pfizer PFE:US $ 15651M 1516M
Puma Biotechnology PBYI:US $ 34.89M 8.57M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Seattle Genetics SGEN:US $ 338.83M 4.33M
Ultragenyx Pharmaceutical RARE:US $ 73.83M 6.04M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M
YTE INCY:US $ 696.02M 128.26M